Cargando…
Pembrolizumab-induced encephalitis in a patient with renal cell carcinoma post nephrectomy: A case report
A new category of immune-related adverse effects has been identified due to increasing use of immune checkpoint inhibitor therapy to treat solid organ cancers. Pembrolizumab approved for renal cell carcinoma also has neurological immune-related adverse effects causing long-term morbidity. We here pr...
Autores principales: | Sharma, Amit, Chapagain, Akhil, Kharel, Sanjeev, Giri, Subarna, Regmi, Arju, Yadav, Rupesh Kumar, Thapaliya, Sahil |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9850121/ https://www.ncbi.nlm.nih.gov/pubmed/36686204 http://dx.doi.org/10.1177/2050313X221149827 |
Ejemplares similares
-
Prevalence of Stroke in Asian Patients with Sickle Cell Anemia: A Systematic Review and Meta-Analysis
por: Kuikel, Sandip, et al.
Publicado: (2021) -
MRI of the brain mimicking autoimmune encephalitis in Sjögren syndrome with chorea: a case report
por: Gajurel, Bikram P., et al.
Publicado: (2023) -
IVIG plus Glucocorticoids versus IVIG Alone in Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with COVID-19: A Systematic Review and Meta-Analysis
por: Rauniyar, Robin, et al.
Publicado: (2022) -
A Case of Pembrolizumab-Induced Diabetic Ketoacidosis and Hyperthyroidism in a Patient With Recurrent Esophageal Adenocarcinoma
por: Salangsang, Jonathan, et al.
Publicado: (2023) -
A case of metastatic renal cell carcinoma successfully treated with deferred cytoreductive nephrectomy following lenvatinib plus pembrolizumab combination therapy
por: Sato, Hiroaki, et al.
Publicado: (2023)